Combinatorial chemoprevention of intestinal neoplasia (original) (raw)

• Slack, J.L. The biology and treatment of acute progranulocytic leukemia. Curr.Opin.Oncol. 11, 9–13 (1999).
  Article CAS Google Scholar
• Johnson, S.C. & Gerber, J.G. Advances in HIV/AIDS therapy. Adv.Intern.Med. 45, 1–40 (2000).
  CAS PubMed Google Scholar
• Badtian, I. & Colebunders, R. Treatment and prevention of multidrug-resistant tuberculosis. Drugs 58, 633–661 (1999).
  Article Google Scholar
• Hong, W.K. & Sporn, M.B. Recent advances in chemoprevention of cancer. Science 278, 1073–1077 (1997).
  Article CAS Google Scholar
• Hawk, E., Lubet, R. & Limburg, P. Chemoprevention in hereditary colorectal cancer syndromes. Cancer 86, 2551–2563 (1999).
  Article CAS Google Scholar
• Giardiello, F.M. NSAID-induced polyp regression in familial adenomatous polyposis patients. Gastroenterol.Clin.North Am. 25, 349–362 (1996).
  Article CAS Google Scholar
• Gran, V.R. et al. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis. Cancer.J.Sci.Am. 6, 13–20 (2000).
  Google Scholar
• Osborne, M.P. Chemoprevention of breast cancer. Surg.Clin.North.Am. 79, 1207–1221 (1999).
  Article CAS Google Scholar
• Papadimitrakopoulou, V.A. et al. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch. Otolaryngol. Head Neck Surg. 125,1083–1089 (1999).
  Article CAS Google Scholar
• Toma, S., Raffo, P., Isnardi, L. & Palumbo, R. Retinoids in lung cancer chemoprevention and treatment. Ann.Oncol. 10, S95–102 (1999).
  Article Google Scholar
• Brenner, D.E. Multiagent chemopreventative agent combinations. J.Cell.Biochem.Suppl. 34, 121–124 (2000).
  Article CAS Google Scholar
• Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159–170 (1996).
  Article CAS Google Scholar
• Dubois, R.N. & Smalley, W.E. Cycloxygenases, NSAIDs and colorectal cancer. J.Gastroenterol. 6, 898–906 (1996).
  Article Google Scholar
• Boolbol, S.K. et al. Cyclooxygenase-2 overexpression and tumour formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56, 2556–2560 (1996).
  CAS PubMed Google Scholar
• Beazer-Barclay, Y. et al. Sulindac suppresses tumourigenesis in the Min mouse. Carcinogenesis 17, 1757–1760 (1996).
  Article CAS Google Scholar
• Su, L.K. et al. Multiple intestinal neoplasia caused by mutation in the murine homolog of the APC gene. Science 256, 668–670 (1992).
  Article CAS Google Scholar
• Wolfe, M.M., Lichtenstein, D.R. & Singh, G. Gastrointestinal toxicity of non-steroidal anti-inflamatory drugs. NEJM. 340, 1888–1899 (1999).
  Article CAS Google Scholar
• Bjorkman, D.J. Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications. Am.J.Med. 105, 8S–10S (1998).
  Article CAS Google Scholar
• Kirschbaum, M.H. & Yarden, Y. The ErbB/HER family of receptor tyrosine kinases: A potential target for chemoprevention of epithelial neoplasms. J.Cell.Biochem. Suppl. 34, 52–60 (2000).
  Article Google Scholar
• Kapitanovic, S. et al. The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology 112,1103–1113 (1997).
  Article CAS Google Scholar
• De Angelis, E. et al. Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families. Int.J.Oncol. 14,437–440 (1999).
  CAS PubMed Google Scholar
• Maurer, C.A. et al. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum.Pathol. 29, 771–777 (1998).
  Article CAS Google Scholar
• Ozgul, C., Karaoz, E., Erdogan, D. & Dursun, A. Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinomas of the colon. Acta.Physiol. Hung. 85,121–128 (1997)
  CAS PubMed Google Scholar
• Shirai, H. et al. Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study. Anticancer.Res. 15,2889–2894 (1995).
  CAS PubMed Google Scholar
• Saeki, T. et al. Differential immunohistochemical detection of amphiregulin and cripto in human normal colonand colorectal tumours. Cancer Res. 52, 3467–3473 (1992).
  CAS PubMed Google Scholar
• Haeri, R., Pippin, J. & Drebin, J.A. Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress Her2/neu. Cancer Res. 60, 560–565 (2000).
  Google Scholar
• Discafani, C.M. et al. Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785). Biochem.Pharmacol. 57, 917–925 (1999).
  Article CAS Google Scholar
• Karnes, W.E. Jr. et al. Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells. Gastroenterology 114, 930–939 (1998).
  Article CAS Google Scholar
• Woodburn, J.R. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol.Ther. 82,241–250 (1999)
  Article CAS Google Scholar
• Normanno, N., De Luca, A., Salomon, D.S. & Ciardiello, F. Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma. CancerDetect.Prev. 22, 62–67 (1998).
  CAS Google Scholar
• Ciardiello, F. et al. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Clin.CancerRes. 5, 909–916 (1999).
  CAS Google Scholar
• Ross, J.S. & Fletcher, J.A. The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy. Semin.CancerBiol. 9, 125–138 (1999).
  Article CAS Google Scholar
• Lewis, G.D. et al. Differential responses of human tumor lines to anti-p185HER2 monoclonal antibodies. Cancer Immunol.Immunother. 37, 255–266 (1993).
  Article CAS Google Scholar
• Williams, C.S., Mann, M. & DuBois, R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908–7916 (1999)
  Article CAS Google Scholar
• Kopp, E. & Ghosh, S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265, 956–959 (1994).
  Article CAS Google Scholar
• He, T.C., Chan, T.A., Vogelstein, B. & Kinzler, K.W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335–345 (1999).
  Article CAS Google Scholar
• Casamassimi, M. et al. EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells Ann.Oncol. 11, 319–325 (2000).
  Article CAS Google Scholar
• Kokoska, E.R., Smith, G.S., Wolff, A.B., Deshpande, Y. & Miller, T.A. Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor-induced proliferation independent of prostaglandin synthesis inhibition. J.Surg.Res. 84, 186–192 (1999).
  Article CAS Google Scholar
• Kinoshita, T. et al. Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells. Biochim.Biophys.Acta 1438,120–130 (1999).
  Article CAS Google Scholar
• Winde, G. et al. Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention. CancerLett. 134, 201–207 (1998).
  CAS Google Scholar
• Vadlamudi, R. et al. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene. 18, 305–314 (1999).
  Article CAS Google Scholar
• Coffey, R.J. et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc.Natl.Acad.Sci. U S A. 94, 657–662 (1997).
  Article CAS Google Scholar
• Reddy, B.S. et al. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Carcinogenesis. 20,1645–1648 (1999).
  Article CAS Google Scholar
• Li, H. et al. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumours, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis 20, 425–430 (1999).
  Article CAS Google Scholar
• Rao, C.V. et al. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res. 51, 4528–4534 (1991).
  CAS PubMed Google Scholar
• Jacoby, R.F. et al. Chemopreventative efficacy of combined piroxicam and difluoromethlornithine treatment of APC mutant min mouse adenomas, and selective toxicity against APC mutant embryos. Cancer Res. 60, 1864–1870 (2000).
  CAS PubMed Google Scholar
• Carbone, P.P. et al. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine. Cancer Epidemiol. Biomarkers Prev. 10, 907–912 (1998).
  Google Scholar
• Laken, S.J. et al. Genotyping by mass spectrometric analysis of short DNA fragments. NatureBiotechnol. 16, 1352–1356 (1998).
  CAS Google Scholar
• Rudbeck, L & Dissing, J. Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. Biotechniques. 25, 588–590 (1998).
  Article CAS Google Scholar
• Roy, S.N. & Horwitz, S.B. A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res. 45, 3856–3863 (1995).
  Google Scholar